Abstract
The pathogenesis of a microbial infection is a complex, dynamic process, constantly evolving within the host. In many instances, the production of virulence determinants is tightly regulated, and their production is modulated in response to the ever-changing environment encountered at the site of infection. It is unlikely that all regulated virulence determinants of a pathogen can be identified in vitro, because it is technically impossible to determine and mimic all of the different environmental stimuli that occur at the site of an infection. This shortcoming hampers our complete understanding of the virulence mechanisms employed by Haemophilus influenzae as well as other human pathogens in general. To overcome this problem, a number of investigators have emphasized the need to study bacterial virulence using organisms engaged in an actual infectious process. Several different methods, such as in vivo expression technology (IVET), signature tagged mutagenesis (STM), differential fluorescence induction (DFI), and microarray analysis, have been created to accomplish this end. Application of these methods to infectious processes caused by various bacterial pathogens has succeeded in identifying collections of genes that define the in vivo lifestyle of a pathogen. These genes can be analyzed and interpreted to gain a deeper understanding of the functions that dictate host specificity, tissue tropism, and disease manifestation (1–6).
This is a preview of subscription content, log in via an institution to check access.
References
Mekalanos J. J. (1992) Environmental signals controlling expression of virulence determinants in bacteria. J Bacteriol. 174, 1–7.
Mahan M. J., Slauch J. M., and Mekalanos J. J. (1993) Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259, 686–688.
Finlay B. B. and Falkow S. (1997) Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61, 136–69.
Heithoff D. M., Conner C. P., and Mahan M. J. (1997) Dissecting the biology of a pathogen during infection. Trends Microbiol. 5, 509–513.
Smith H. (1998) What happens to bacterial pathogens in vivo? Trends Microbiol. 6, 239–243.
Handfield M. and Levesque R. C. (1999) Strategies for isolation of in-vivo expressed genes from bacteria. FEMS Microbiol. Rev. 23, 69–91.
Handfield M., Brady L. J., Progulske-Fox A., and Hillman J. D. (2000) IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol. 8, 336–339.
Handfield M., Brady L. J., Progulske-Fox A., and Hillman J. D. Probing for bacterial antigens induced specifically in human infections. Infect. Immun. Submitted.
Porras O., Caugant D. A., Lagergard T., and Svanborg-Eden C. (1986) Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect. Immun. 53, 71–78.
Musser J. M., Kroll J. S., Granoff D. M., Moxon E. R., Brodeur B. R., Campos J., et al. (1990) Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev. Infect. Dis. 12, 75–111.
Coligan J. E., Dunn B. M., Ploegh H. L., Speicher D. W., and Wingfield P. T. eds. (1997) Chemical modification of proteins: basic protocol #2. Addition of isothiocyanati, in Current Protocols in Protein Science. John Wiley, New York, p. 15.2.7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Handfield, M., Seifert, T., Hillman, J.D. (2003). In Vivo Expression of Bacterial Genes During Human Infections. In: Herbert, M.A., Hood, D.W., Moxon, E.R. (eds) Haemophilus influenzae Protocols. Methods in Molecular Medicine™, vol 71. Humana Press. https://doi.org/10.1385/1-59259-321-6:225
Download citation
DOI: https://doi.org/10.1385/1-59259-321-6:225
Publisher Name: Humana Press
Print ISBN: 978-0-89603-928-5
Online ISBN: 978-1-59259-321-7
eBook Packages: Springer Protocols